The latest research report prenatal testing and newborn screening report offers an industry-wide and economy-wide analysis of the market along with supply and demand dynamics, sales, and production and manufacturing capacity. The research elaborates on the crucial information pertaining to the regional market share. It simultaneously focuses on the significant details about the growth patterns of each regional market. The report closely studies the growth trajectory of the global prenatal testing and newborn screening market.
The report prenatal testing and newborn screening report also provides an extensive analysis of the key players with regards to their market size, market share, sales volume, production and consumption rate, expansion strategies, and overall competitive scenario. The chromosomal anomalies include benefits by genetic material, which can differ from chromosome to chromosome, and thus, have applications in prenatal testing. In April 2019, Progenity Inc. introduced the Resura Prenatal Test, which is a non-invasive and personalized prenatal check for monogenetic diseases. Such newer tests are ensuring safety of infants, which is estimated to drive market growth in the coming future.
It further fragments the global prenatal testing and newborn screening market into a broad product spectrum. The global prenatal testing and newborn screening health emergency has beleaguered the global economy, thereby disrupting this particular business domain’s functioning mechanism. Additionally, testing, such as the Trisomy 21 test, is considered superior than other modalities screenings.
To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/prenatal-testing-and-newborn-screening-market
Regionally, the North American region dominated the prenatal testing and newborn screening market in 2019 and is estimated to remain dominant over the forecast period. This growth is attributable to the advent of technologically advanced healthcare system coupled with developments of whole-genome sequencing. Additionally, the early adoption of advanced healthcare is estimated to benefit the growth of the market.
Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
• U.S.
• Canada
• Mexico
Europe
• Germany
• U.K.
• France
• BENELUX
• Rest of Europe
Type Outlook (Revenue, USD Billion; 2017-2027)
• Prenatal Testing
• Newborn Screening
Test Type Outlook (Revenue, USD Billion; 2017-2027)
• Non-Invasive
• Invasive
